Accelerated Corneal Cross-linking With Different Riboflavin Solutions
NCT03187912
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Keratoconus
Interventions
DRUG:
Riboflavin
Sponsor
Medical University of Vienna